ADPT insider transactions
Adaptive Biotechnologies Corporation (ADPT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ADPT
- Director Hershberg Robert exercised 15,000 shares at a strike of $6.32 and sold $748,208 worth of shares (30,664 units at $24.40), decreasing direct ownership by 25% to 46,683 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M exercised 600,000 shares at a strike of $6.55 and sold $14,882,166 worth of shares (600,000 units at $24.80) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Neupert Peter M sold $3,135,850 worth of shares (124,690 units at $25.15) and exercised 15,000 shares at a strike of $6.32, decreasing direct ownership by 46% to 130,625 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $75,000 worth of shares (3,000 units at $25.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.75% to 396,989 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $31,176 worth of shares (1,299 units at $24.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.32% to 399,989 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S exercised 284,800 shares at a strike of $6.55 and sold $10,780,409 worth of shares (492,400 units at $21.89) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 812,058 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $115,000 worth of shares (5,000 units at $23.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 401,288 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis exercised 105,762 shares at a strike of $8.91 and sold $2,389,164 worth of shares (105,762 units at $22.59) as part of a pre-agreed trading plan (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $8,501,149 worth of shares (386,240 units at $22.01) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 1,019,658 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis exercised 75,621 shares at a strike of $8.75 and sold $2,157,683 worth of shares (95,842 units at $22.51) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 230,713 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $10,714 worth of shares (487 units at $22.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 406,288 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Ofc Imm Med Benzeno Sharon exercised 114,329 shares at a strike of $7.75 and sold $3,503,510 worth of shares (165,802 units at $21.13) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 221,278 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $102,500 worth of shares (5,000 units at $20.50) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 406,775 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Griffin Michelle Renee exercised 52,084 shares at a strike of $7.80 and sold $1,051,055 worth of shares (52,084 units at $20.18) as part of a pre-agreed trading plan (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $1,847,942 worth of shares (106,160 units at $17.41) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 1,405,898 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $95,000 worth of shares (5,000 units at $19.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 411,775 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis exercised 19,521 shares at a strike of $8.85 and sold $695,070 worth of shares (39,741 units at $17.49) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 250,934 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $198,000 worth of shares (11,000 units at $18.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 416,775 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle sold $40,620 worth of shares (3,115 units at $13.04), decreasing direct ownership by 1% to 256,725 units (SEC Form 4) to satisfy tax liability4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie sold $270,897 worth of shares (19,037 units at $14.23) as part of a pre-agreed trading plan and exercised 14,707 shares at a strike of $8.46, decreasing direct ownership by 1% to 377,802 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 44,166 shares at a strike of $8.46 and sold $798,423 worth of shares (57,180 units at $13.96) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 382,132 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Lo Francis4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Robins Harlan S4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Robins Chad M4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 44,166 shares at a strike of $6.55 and sold $2,374,058 worth of shares (179,703 units at $13.21), decreasing direct ownership by 21% to 507,934 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Griffin Michelle Renee sold $214,131 worth of shares (15,394 units at $13.91), decreasing direct ownership by 50% to 15,625 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis sold $430,749 worth of shares (30,593 units at $14.08), decreasing direct ownership by 10% to 291,374 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $544,421 worth of shares (41,338 units at $13.17), decreasing direct ownership by 9% to 427,775 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Ofc Imm Med Benzeno Sharon sold $831,067 worth of shares (63,103 units at $13.17), decreasing direct ownership by 19% to 272,751 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle sold $245,910 worth of shares (18,672 units at $13.17), decreasing direct ownership by 7% to 259,840 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $6,193,403 worth of shares (470,266 units at $13.17), decreasing direct ownership by 24% to 1,522,058 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $6,192,099 worth of shares (470,167 units at $13.17), decreasing direct ownership by 17% to 2,301,113 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 68,328 shares at a strike of $8.53 and sold $1,211,737 worth of shares (81,342 units at $14.90), decreasing direct ownership by 2% to 643,471 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis sold $574,537 worth of shares (38,074 units at $15.09), decreasing direct ownership by 11% to 321,967 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Neupert Peter M was granted 15,625 shares, increasing direct ownership by 7% to 240,315 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Hershberg Robert was granted 15,625 shares, increasing direct ownership by 33% to 62,347 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis was granted 44,063 shares, increasing direct ownership by 14% to 360,041 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan was granted 121,875 shares, increasing direct ownership by 35% to 469,113 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Ofc Imm Med Benzeno Sharon was granted 39,063 shares, increasing direct ownership by 13% to 335,854 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie was granted 81,250 shares, increasing direct ownership by 14% to 656,485 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S was granted 837,033 shares, increasing direct ownership by 72% to 1,992,324 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle was granted 61,875 shares, increasing direct ownership by 29% to 278,512 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Owen Katey Einterz was granted 15,625 shares, increasing direct ownership by 22% to 88,254 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Griffin Michelle Renee was granted 15,625 shares, increasing direct ownership by 102% to 31,019 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M was granted 837,033 shares, increasing direct ownership by 43% to 2,771,280 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Griffin Michelle Renee exercised 48,044 shares at a strike of $3.99 and sold $735,073 worth of shares (48,044 units at $15.30) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 79,809 shares at a strike of $9.05 and sold $1,493,428 worth of shares (92,823 units at $16.09), decreasing direct ownership by 2% to 575,235 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $392,329 worth of shares (24,233 units at $16.19), decreasing direct ownership by 2% to 1,155,291 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $8,320,613 worth of shares (524,998 units at $15.85), decreasing direct ownership by 21% to 1,934,247 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle exercised 2,145 shares at a strike of $12.14 and sold $39,597 worth of shares (2,145 units at $18.46) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $799,105 worth of shares (42,788 units at $18.68), decreasing direct ownership by 4% to 1,179,524 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)